NHX
- Product code
- NHX
- Device name
- Antibodies, Anti-Cyclic Citrullinated Peptide (Ccp)
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.5775
- Medical specialty
- Immunology
- Marketing pathway
- 510(K)
- Flag
- Third-party review eligible
- 510(k) clearances (all years, FDA)
- 21 (all years; only the last 3 years are listed here)
FDA classification definition
The device is used for the detection of anti-cyclic citrullinated peptide (CCP) antibodies in human serum or plasma as an aid in the diagnosis of rheumatoid arthritis.
Official FDA classification page: NHX
Classification and pathway per current FDA publications. Data from openFDA (CC0).